New 3D ultrasound aims to improve liver cancer treatment monitoring

NCT ID NCT05705219

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a special 3D ultrasound technique can help doctors better monitor how liver tumors respond to treatment. About 80 adults with liver cancer that started in the colon or rectum will be scanned before and during therapy. The goal is to see if this imaging tool can provide clear and useful information to guide treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stanford University, School of Medicine

    RECRUITING

    Palo Alto, California, 94305, United States

  • Thomas Jefferson Hospital

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • University of California, San Diego

    RECRUITING

    San Diego, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.